McCann H, Stevens CH, Cartwright H, Halliday GM. alpha-Synucleinopathy phenotypes. Parkinsonism Relat Disord. 2014;20(Suppl 1):S62–67.

Article  PubMed  Google Scholar 

Li G, Ma J, Cui S, He Y, Xiao Q, Liu J, Chen S. Parkinson’s disease in China: a forty-year growing track of bedside work. Transl Neurodegener. 2019;8:22.

Article  PubMed  PubMed Central  Google Scholar 

Yang JX, Chen L. Economic Burden Analysis of Parkinson’s Disease Patients in China. Parkinsons Dis 2017, 2017;8762939.

Taylor J-P, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, Allan LM, Thomas AJ, O’Brien JT. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19(2):157–69.

Article  PubMed  Google Scholar 

Kon T, Tomiyama M, Wakabayashi K. Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases. Neuropathology. 2020;40(1):30–9.

Article  PubMed  Google Scholar 

Malfertheiner K, Stefanova N, Heras-Garvin A. The concept of α-synuclein strains and how different conformations may explain distinct neurodegenerative disorders. Front Neurol. 2021;12:737195. https://doi.org/10.3389/fneur.2021.737195.

Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van den Haute C, Melki R. Baekelandt V: α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature. 2015;522(7556):340–.

Article  PubMed  Google Scholar 

Yang Y, Zhang Z. alpha-Synuclein pathology from the body to the brain: so many seeds so close to the central soil. Neural Regen Res. 2024;19(7):1463–72.

Article  PubMed  Google Scholar 

Yang Y, Garringer HJ, Shi Y, Lovestam S, Peak-Chew S, Zhang X, Kotecha A, Bacioglu M, Koto A, Takao M, et al. New SNCA mutation and structures of α-synuclein filaments from juvenile-onset synucleinopathy. Acta Neuropathol. 2023;145(5):561–72.

Article  PubMed  PubMed Central  Google Scholar 

van der Zande JJ, Booij J, Scheltens P, Raijmakers PG, Lemstra AW. [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies. Eur J Nucl Med Mol Imaging. 2016;43(6):1060–6.

Article  PubMed  PubMed Central  Google Scholar 

Thomas AJ, Attems J, Colloby SJ, O’Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z. Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology. 2017;88(3):276–83.

Article  PubMed  PubMed Central  Google Scholar 

McGlinchey RP, Ni X, Shadish JA, Jiang J, Lee JC. The N terminus of α-synuclein dictates fibril formation. Proc Natl Acad Sci USA 2021;118(35).

Yang Y, Shi Y, Schweighauser M, Zhang X, Kotecha A, Murzin AG, Garringer HJ, Cullinane PW, Saito Y, Foroud T, et al. Structures of α-synuclein filaments from human brains with Lewy pathology. Nature. 2022;610(7933):791–.

Article  PubMed  Google Scholar 

Gracia P, Camino JD, Volpicelli-Daley L, Crema N. Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease. Int J Mol Sci 2020;21(21).

Lima VA, do Nascimento LA, Eliezer D, Follmer C. Role of Parkinson’s Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde. ACS Chem Neurosci. 2019;10(1):690–703.

Article  PubMed  Google Scholar 

Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JM, Armanini M, Ryan A, et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 2000;25(1):239–52.

Article  PubMed  Google Scholar 

Goedert M, Jakes R, Spillantini MG. The Synucleinopathies: Twenty Years On. J Parkinsons Disease. 2017;7:S53–71.

Google Scholar 

Ma J, Gao J, Wang J, Xie A. Prion-like mechanisms in parkinson’s disease. Front Neurosci. 2019;13:552. https://doi.org/10.3389/fnins.2019.00552.

Paciotti S, Bellomo G, Gatticchi L, Parnetti L. Are we ready for detecting α-synuclein prone to aggregation in patients? The case of protein-misfolding cyclic amplification and real-time quaking-induced conversion as diagnostic tools. Front Neurol. 2018;9:415. https://doi.org/10.3389/fneur.2018.00415.

Atik A, Stewart T, Zhang J. Alpha-Synuclein as a Biomarker for Parkinson’s Disease. Brain Pathol. 2016;26(3):410–8.

Article  PubMed  PubMed Central  Google Scholar 

Fernandes Gomes B, Farris CM, Ma Y, Concha-Marambio L, Lebovitz R, Nellgard B, Dalla K, Constantinescu J, Constantinescu R, Gobom J, et al. alpha-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders. Parkinsonism Relat Disord. 2023;117:105807.

Article  PubMed  Google Scholar 

Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, et al. Assessment of heterogeneity among participants in the Parkinson’s Progression Markers Initiative cohort using alpha-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 2023;22(5):407–17.

Article  PubMed  PubMed Central  Google Scholar 

Tarutani A, Hasegawa M. Ultrastructures of alpha-Synuclein Filaments in Synucleinopathy Brains and Experimental Models. J Mov Disord. 2024;17(1):15–29.

Article  PubMed  Google Scholar 

Fink AL. The aggregation and fibrillation of alpha-synuclein. Acc Chem Res. 2006;39(9):628–34.

Article  PubMed  Google Scholar 

Alam P, Bousset L, Melki R, Otzen DE. α-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities. J Neurochem. 2019;150(5):522–34.

Article  PubMed  Google Scholar 

Candelise N, Baiardi S, Franceschini A, Rossi M, Parchi P. Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids. Acta Neuropathol Commun 2020;8(1).

Candelise N, Schmitz M, Llorens F, Villar-Pique A, Cramm M, Thom T, Correia SMS, Gomes da, Cunha JE, Moebius W, Outeiro TF et al. Seeding variability of different alpha synuclein strains in synucleinopathies. Annals of Neurology 2019;85(5):691–703.

Kang UJ, Boehme AK, Fairfoul G, Shahnawaz M, Ma TC, Hutten SJ, Green A, Soto C. Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson’s disease. Mov Disord. 2019;34(4):536–44.

Article  PubMed  PubMed Central  Google Scholar 

Iranzo A, Fairfoul G, Ayudhaya ACN, Serradell M, Gelpi E, Vilaseca I, Sanchez-Valle R, Gaig C, Santamaria J, Tolosa E, et al. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study. Lancet Neurol. 2021;20(3):203–12.

Article  PubMed  Google Scholar 

Stefani A, Iranzo A, Holzknecht E, Perra D, Bongianni M, Gaig C, Heim B, Serradell M, Sacchetto L, Garrido A, et al. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder. Brain. 2021;144:1118–26.

Article  PubMed  Google Scholar 

Rossi M, Baiardi S, Teunissen CE, Quadalti C, van de Beek M, Mammana A, Stanzani-Maserati M, van der Flier WM, Sambati L, Zenesini C, et al. Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies. Neurology. 2021;97(9):E930–40.

Article  PubMed  PubMed Central  Google Scholar 

Bargar C, Wang W, Gunzler SA, LeFevre A, Wang Z, Lerner AJ, Singh N, Tatsuoka C, Appleby B, Zhu X et al. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies. Acta Neuropathol Commun 2021;9(1).

De Luca CMG, Elia AE, Portaleone SM, Cazzaniga FA, Rossi M, Bistaffa E, De Cecco E, Narkiewicz J, Salzano G, Carletta O et al. Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy. Translational Neurodegeneration 2019;8(1).

Jung BC, Lim Y-J, Bae E-J, Lee JS, Choi MS, Lee MK, et al. Amplification of distinct α-synuclein fibril conformers through protein misfolding cyclic amplification. Exp Mol Med. 2017;49(4):e314. https://doi.org/10.1038/emm.2017.1.

Sunde M, Serpell LC, Bartlam M, Fraser PE, Pepys MB, Blake CC. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol. 1997;273(3):729–39.

Article  PubMed  Google Scholar 

Liu D, Guo J-J, Su J-H, Svanbergsson A, Yuan L, Haikal C, Li W, Gouras G, Li J-Y. Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions. Translational Neurodegeneration 2021;10(1).

Peelaerts W, Bousset L, Baekelandt V, Melki R. E-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences. Cell Tissue Res. 2018;373(1):195–212.

Article  PubMed  Google Scholar 

Rey NL, Bousset L, George S, Madaj Z, Meyerdirk L, Schulz E, Steiner JA, Melki R, Brundin P. α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb. Acta Neuropathol Commun 2019;7(1).

Lau A, So RWL, Lau HHC, Sang JC, Ruiz-Riquelme A, Fleck SC, Stuart E, Menon S, Visanji NP, Meisl G, et al. α-Synuclein strains target distinct brain regions and cell types. Nat Neurosci. 2020;23(1):21–.

Article  PubMed  Google Scholar 

Suzuki G, Imura S, Hosokawa M, Katsumata R, Nonaka T, Hisanaga S-I, et al. α-synuclein strains that cause distinct pathologies differentially inhibit proteasome. Elife. 2020;9:e56825. https://doi.org/10.7554/eLife.56825.

Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A, Kretzschmar H, Hengerer B, Kostka M. Different species of α-synuclein oligomers induce calcium influx and seeding. J Neurosci. 2007;27(34):9220–32.

Article  PubMed  PubMed Central  Google Scholar 

Recasens A, Dehay B, Bove J, Carballo-Carbajal I, Dovero S, Perez-Villalba A, Fernagut P-O, Blesa J, Parent A, Perier C, et al. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol. 2014;75(3):351–62.

Article  PubMed  Google Scholar 

Bourdenx M, Nioche A, Dovero S, Arotcarena ML, Camus S, Porras G, Thiolat ML, Rougier NP, Prigent A, Aubert P et al. Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates. Sci Adv 2020;6(20).

Thomsen MB, Ferreira SA, Schacht AC, Jacobsen J, Simonsen M, Betzer C, et al. PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats. Neurobiol Dis. 2021;149:105229. https://doi.org/10.1016/j.nbd.2020.105229.

Luk KC, Kehm V, Carroll J, Zhang B, O’Brien P, Trojanowski JQ, Lee VMY. Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice. Science. 2012;338(6109):949–53.

Article  PubMed  PubMed Central